Abstract
Introduction
Antibodies are an essential research tool for labeling surface proteins but can potentially influence the behavior of proteins and cells to which they bind. Because of this, researchers and clinicians are interested in the persistence of these antibodies, particularly for live-cell applications. We developed an easily adoptable method for researchers to characterize antibody removal timelines for any cell–antibody combination, with the benefit of studying broad, hypothesized mechanisms of antibody removal.
Methods
We developed a method using four experimental conditions to elucidate the contributions of possible factors influencing antibody removal: cell proliferation, internalization, permanent dissociation, and environmental perturbation. This method was tested on adipose-derived stem cells and a human lung fibroblast cell line with anti-CD44, CD90, and CD105 antibodies. The persistence of the primary antibody was probed using a fluorescent secondary antibody daily over 10 days. Relative contributions by the antibody removal mechanisms were quantified based on differences between the four culture conditions.
Results
Greater than 90% of each antibody tested was no longer present on the surface of the two cell types after 5 days, with removal observed in as little as 1 day post-labeling. Anti-CD90 antibody was primarily removed by environmental perturbation, anti-CD105 antibody by internalization, and anti-CD44 antibody by a combination of all four factors.
Conclusions
Antibody removal mechanism depended on the specific antibody tested, while removal timelines for the same antibody depended more on cell type. This method should be broadly relevant to researchers interested in quantifying an initial timeframe for uninhibited use of antibody-labeled cells.
Similar content being viewed by others
References
Ackerman, M. E., D. Pawlowski, and K. D. Wittrup. Effect of antigen turnover rate and expression level on antibody penetration into tumor spheroids. Mol. Cancer Ther. 7:2233–2240, 2008.
Alon, R., E. A. Bayer, and M. Wilchek. Affinity cleavage of cell surface antibodies using the avidin-biotin system. J. Immunol. Methods 165:127–134, 1993.
Alt, E., Y. Yan, S. Gehmert, Y. H. Song, A. Altman, S. Gehmert, D. Vykoukal, and X. Bai. Fibroblasts share mesenchymal phenotypes with stem cells, but lack their differentiation and colony-forming potential. Biol. Cell 103:197–208, 2011.
Audran, R., B. Drenou, F. Wittke, A. Gaudin, T. Lesimple, and L. Toujas. Internalization of human macrophage surface antigens induced by monoclonal antibodies. J. Immunol. Methods 188:147–154, 1995.
Belleudi, F., E. Marra, F. Mazzetta, L. Fattore, M. R. Giovagnoli, R. Mancini, L. Aurisicchio, M. R. Torrisi, and G. Ciliberto. Monoclonal antibody-induced ErbB3 receptor internalization and degradation inhibits growth and migration of human melanoma cells. Cell Cycle 11:1455–1467, 2012.
Bergtold, A., D. D. Desai, A. Gavhane, and R. Clynes. Cell surface recycling of internalized antigen permits dendritic cell priming of B cells. Immunity 23:503–514, 2005.
Congdon, E. E., J. Gu, H. B. Sait, and E. M. Sigurdsson. Antibody uptake into neurons occurs primarily via clathrin-dependent Fcgamma receptor endocytosis and is a prerequisite for acute tau protein clearance. J. Biol. Chem. 288:35452–35465, 2013.
Davies, O. G., P. R. Cooper, R. M. Shelton, A. J. Smith, and B. A. Scheven. Isolation of adipose and bone marrow mesenchymal stem cells using CD29 and CD90 modifies their capacity for osteogenic and adipogenic differentiation. J. Tissue. Eng. 6:1–10, 2015.
des Roziers, N. B., and S. Squalli. Removing IgG antibodies from intact red cells: comparison of acid and EDTA, heat, and chloroquine elution methods. Transfusion 37:497–501, 1997.
Dominici, M. L. B. K., K. Le Blanc, I. Mueller, I. Slaper-Cortenbach, F. C. Marini, D. S. Krause, R. J. Deans, A. Keating, D. J. Prockop, and E. M. Horwitz. Minimal criteria for defining multipotent mesenchymal stromal cells. The International Society for Cellular Therapy position statement. Cytotherapy 8:315–317, 2006.
Francis, S. L., S. Duchi, C. Onofrillo, C. Di Bella, and P. F. M. Choong. Adipose-derived mesenchymal stem cells in the use of cartilage tissue engineering: the need for a rapid isolation procedure. Stem Cells Int. 2018:8947548, 2018.
Gossett, D. R., W. M. Weaver, A. J. Mach, S. C. Hur, H. T. K. Tse, W. Lee, H. Amini, and D. Di Carlo. Label-free cell separation and sorting in microfluidic systems. Anal. Bioanal. Chem. 397:3249–3267, 2010.
Jiskoot, W., E. C. Beuvery, A. A. de Koning, J. N. Herron, and D. J. Crommelin. Analytical approaches to the study of monoclonal antibody stability. Pharm. Res. 7:1234–1241, 1990.
Jones, A. R., C. C. Stutz, Y. Zhou, J. D. Marks, and E. V. Shusta. Identifying blood–brain-barrier selective single-chain antibody fragments. Biotechnol. J. 9:664–674, 2014.
Khazaeli, M. B., R. M. Conry, and A. F. LoBuglio. Human immune response to monoclonal antibodies. J. Immunother. 15:42–52, 1994.
Kiese, S., A. Papppenberger, W. Friess, and H. C. Mahler. Shaken, not stirred: mechanical stress testing of an IgG1 antibody. J. Pharm. Sci. 97:4347–4366, 2008.
Kulin, S., R. Kishore, J. B. Hubbard, and K. Helmerson. Real-time measurement of spontaneous antigen-antibody dissociation. Biophys. J . 83:1965–1973, 2002.
Kyriakos, R. J., L. B. Shih, G. L. Ong, K. Patel, D. M. Goldenberg, and M. J. Mattes. The fate of antibodies bound to the surface of tumor cells in vitro. Cancer Res. 52:835–842, 1992.
Le Basle, Y., P. Chennell, N. Tokhadze, A. Astier, and V. Sautou. Physicochemical stability of monoclonal antibodies: a review. J. Pharm. Sci. 109:169–190, 2020.
Leemans, A., M. De Schryver, W. Van der Gucht, A. Heykers, I. Pintelon, A. L. Hotard, M. L. Moore, J. A. Melero, J. S. McLellan, B. S. Graham, L. Broadbent, U. F. Power, G. Caljon, P. Cos, L. Maes, and P. Delputte. Antibody-induced internalization of the human respiratory syncytial virus fusion protein. J. Virol. 91:2017.
Li, Y., P. C. Liu, Y. Shen, M. D. Snavely, and K. Hiraga. A cell-based internalization and degradation assay with an activatable fluorescence-quencher probe as a tool for functional antibody screening. J. Biomol. Screen. 20:869–875, 2015.
Mason, J. T., and T. J. O’leary. Effects of formaldehyde fixation on protein secondary structure: a calorimetric and infrared spectroscopic investigation. J. Histochem. Cytochem. 39:225–229, 1991.
Mason, D. W., and A. F. Williams. The kinetics of antibody binding to membrane antigens in solution and at the cell surface. Biochem. J. 187:1–20, 1980.
Mathieson, T., H. Franken, J. Kosinski, N. Kurzawa, N. Zinn, G. Sweetman, D. Poeckel, V. S. Ratnu, M. Schramm, I. Becher, and M. Steidel. Systematic analysis of protein turnover in primary cells. Nat. Commun. 9:1–10, 2018.
Matzku, S., E. B. Bröcker, J. Brüggen, W. G. Dippold, and W. Tilgen. Modes of binding and internalization of monoclonal antibodies to human melanoma cell lines. Cancer Res. 46:3848–3854, 1986.
Mildmay-White, A., and W. Khan. Cell surface markers on adipose-derived stem cells: a systematic review. Curr. Stem Cell Res. Ther. 12:484–492, 2017.
Mosedale, D. E., J. C. Metcalfe, and D. J. Grainger. Optimization of immunofluorescence methods by quantitative image analysis. J. Histochem. Cytochem. 44:1043–1050, 1996.
Nielsen, U. B., D. B. Kirpotin, E. M. Pickering, D. C. Drummond, and J. D. Marks. A novel assay for monitoring internalization of nanocarrier coupled antibodies. BMC Immunol. 7:24, 2006.
Novak-Hofer, I., H. P. Amstutz, J. J. Morgenthaler, and P. A. Schubiger. Internalization and degradation of monoclonal antibody chCE7 by human neuroblastoma cells. Int. J. Cancer 57:427–432, 1994.
Nowak, C., J. K. Cheung, S. M. Dellatore, A. Katiyar, R. Bhat, J. Sun, G. Ponniah, A. Neill, B. Mason, A. Beck, and H. Liu. Forced degradation of recombinant monoclonal antibodies: a practical guide. MAbs 9:1217–1230, 2017.
Otsu, N. A threshold selection method from gray-level histograms. IEEE Trans. Syst. Man Cybernet. B 9:62–66, 1979.
Qing, X., M. Pitashny, D. B. Thomas, F. J. Barrat, M. P. Hogarth, and C. Putterman. Pathogenic anti-DNA antibodies modulate gene expression in mesangial cells: involvement of HMGB1 in anti-DNA antibody-induced renal injury. Immunol. Lett. 121:61–73, 2008.
Roda, B., P. Reschiglian, A. Zattoni, F. Alviano, G. Lanzoni, R. Costa, A. Di Carlo, C. Marchionni, M. Franchina, L. Bonsi, and G. P. Bagnara. A tag-less method of sorting stem cells from clinical specimens and separating mesenchymal from epithelial progenitor cells. Cytom Part B Clin Cy 76:285–290, 2009.
Sarnik, S. A., B. A. Sutermaster, and E. M. Darling. Mass-added density modulation for sorting cells based on differential surface protein levels. Cytom. A 2020. https://doi.org/10.1002/cyto.a.24192.
Schaffar, L., A. Dallanegra, J. P. Breittmayer, S. Carrel, and M. Fehlmann. Monoclonal antibody internalization and degradation during modulation of the CD3/T-cell receptor complex. Cell. Immunol. 116:52–59, 1988.
Sears, H. F., D. J. Bagli, D. Herlyn, E. DeFreitas, H. Suzuki, G. Steele, and H. Koprowski. Human immune response to monoclonal antibody administration is dose-dependent. Arch. Surg. 122:1384–1388, 1987.
Shih, L. B., S. R. Thorpe, G. L. Griffiths, H. Diril, G. L. Ong, H. J. Hansen, D. M. Goldenberg, and M. J. Mattes. The processing and fate of antibodies and their radiolabels bound to the surface of tumor cells in vitro: a comparison of nine radiolabels. J. Nucl. Med. 35:899–908, 1994.
Specht, E. A., E. Braselmann, and A. E. Palmer. A critical and comparative review of fluorescent tools for live-cell imaging. Annu. Rev. Physiol. 79:93–117, 2017.
St-Pierre, C. A., D. Leonard, S. Corvera, E. A. Kurt-Jones, and R. W. Finberg. Antibodies to cell surface proteins redirect intracellular trafficking pathways. Exp. Mol. Pathol. 91:723–732, 2011.
Trischitta, V., K. Y. Wong, A. Brunetti, R. Scalisi, R. Vigneri, and I. D. Goldfine. Endocytosis, recycling, and degradation of the insulin receptor. Studies with monoclonal antireceptor antibodies that do not activate receptor kinase. J. Biol. Chem. 264:5041–5046, 1989.
Trowbridge, I. S., and F. Lopez. Monoclonal antibody to transferrin receptor blocks transferrin binding and inhibits human tumor cell growth in vitro. PNAS 79:1175–1179, 1982.
Tsaltas, G., and C. H. Ford. Cell membrane antigen-antibody complex dissociation by the widely used glycine-HCL method: an unreliable procedure for studying antibody internalization. Immunol. Invest. 22:1–12, 1993.
Tsoukas, C. D., B. Landgraf, J. Bentin, M. Valentine, M. Lotz, J. H. Vaughan, and D. A. Carson. Activation of resting T lymphocytes by anti-CD3 (T3) antibodies in the absence of monocytes. J. Immunol. 135:1719–1723, 1985.
Wallberg, M., A. Recino, J. Phillips, D. Howie, M. Vienne, C. Paluch, M. Azuma, F. S. Wong, H. Waldmann, and A. Cooke. Anti-CD 3 treatment up-regulates programmed cell death protein-1 expression on activated effector T cells and severely impairs their inflammatory capacity. Immunology 151:248–260, 2017.
Wei, B., K. Berning, C. Quan, and Y. T. Zhang. Glycation of antibodies: modification, methods and potential effects on biological functions. MAbs 9:586–594, 2017.
Yokota, N., M. Hattori, T. Ohtsuru, M. Otsuji, S. Lyman, K. Shimomura, and N. Nakamura. Comparative clinical outcomes after intra-articular injection with adipose-derived cultured stem cells or noncultured stromal vascular fraction for the treatment of knee osteoarthritis. Am. J. Sports Med. 47:2577–2583, 2019.
Acknowledgments
The authors would like to acknowledge Ryan Dubay for creating the MATLAB image analysis script used in the study. Funding support was provided by NIH/NIAMS (R01 AR063642, EMD) and Brown University’s Undergraduate Teaching and Research Award (OWB).
Author Contributions
MED, OWB, and EMD designed all experiments. OWB conducted preliminary optimization experiments, initial antibody removal iterations, and antibody dilution/concentration experiments. MED carried out all remaining experiments and iterations as well as conducted final analysis and interpretation of data. MED and EMD wrote the manuscript with figure contributions from OWB.
Conflict of interest
Megan E. Dempsey, Olivia Woodford-Berry, and Eric M. Darling declare that they have no conflicts of interest.
Ethical Standards
No human or animal studies were carried out by the authors for this article.
Author information
Authors and Affiliations
Corresponding author
Additional information
Associate Editor Monica M. Burdick oversaw the review of this article.
Publisher's Note
Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.
Supplementary Information
Below is the link to the electronic supplementary material.
Rights and permissions
About this article
Cite this article
Dempsey, M.E., Woodford-Berry, O. & Darling, E.M. Quantification of Antibody Persistence for Cell Surface Protein Labeling. Cel. Mol. Bioeng. 14, 267–277 (2021). https://doi.org/10.1007/s12195-021-00670-3
Received:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1007/s12195-021-00670-3